Exchange: NASDAQ·Updated 07:34 PM EDT
Upcoming Earnings: Q2 '26

Reports: Aug 05After Hours

Estimated EPS

-$0.33

Estimated Rev

$32.55M

$RXST Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.38 down -90.00% YoY • Reported revenue of $30.89M down -18.48% YoY • RxSight expects to incur net operating losses and negative cash flows for the foreseeable future, despite anticipating revenue growth from expanded sales and marketing efforts, with current cash sufficient for at least 12 months.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.33
--
--
N/A
Q1 '26
-$0.30
-$0.38
-27.14%
MISSED
Q4 '25
-$0.33
-$0.22
34.27%
BEAT
Q3 '25
-$0.38
-$0.24
36.12%
BEAT
Q2 '25
-$0.25
-$0.29
-17.17%
MISSED

Advertisement|Remove ads.